BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24253403)

  • 1. Pneumococcal vaccination rates in children with sickle cell disease.
    Nero AC; Akuete K; Leasure Reeves S; Dombkowski KJ
    J Public Health Manag Pract; 2014; 20(6):587-90. PubMed ID: 24253403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal and Meningococcal Vaccination among Michigan Children with Sickle Cell Disease.
    Wagner AL; Shrivastwa N; Potter RC; Lyon-Callo SK; Boulton ML
    J Pediatr; 2018 May; 196():223-229. PubMed ID: 29555094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life.
    Adamkiewicz TV; Silk BJ; Howgate J; Baughman W; Strayhorn G; Sullivan K; Farley MM
    Pediatrics; 2008 Mar; 121(3):562-9. PubMed ID: 18310206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumococcal vaccination coverage among children with sickle cell anemia, sickle cell trait, and normal hemoglobin.
    Reeves SL; Jary HK; Gondhi JP; Kleyn M; Wagner AL; Dombkowski KJ
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27282. PubMed ID: 29905397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent invasive pneumococcal disease in children--host factors and vaccination response.
    Ingels HA
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of pneumococcal polysaccharide vaccine administration and incidence of invasive pneumococcal disease in children in Jamaica aged over 4 years with sickle cell disease diagnosed by newborn screening.
    Hardie R; King L; Fraser R; Reid M
    Ann Trop Paediatr; 2009 Sep; 29(3):197-202. PubMed ID: 19689861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.
    Halasa NB; Shankar SM; Talbot TR; Arbogast PG; Mitchel EF; Wang WC; Schaffner W; Craig AS; Griffin MR
    Clin Infect Dis; 2007 Jun; 44(11):1428-33. PubMed ID: 17479937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Invasive Pneumococcal Disease in Children with Sickle Cell Disease in England: A National Observational Cohort Study, 2010-2015.
    Oligbu G; Collins S; Sheppard C; Fry N; Dick M; Streetly A; Ladhani S
    Arch Dis Child; 2018 Jul; 103(7):643-647. PubMed ID: 29282225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the Immunogenic Response of a Single Center's Pneumococcal Vaccination Protocol in Sickle Cell Disease.
    Santoro JD; Myers L; Kanter J
    J Pediatr Hematol Oncol; 2016 Apr; 38(3):e102-6. PubMed ID: 26886376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paediatric immunisation and chemoprophylaxis in a Ugandan sickle cell disease clinic.
    Chen CJ; Bakeera-Kitaka S; Mupere E; Kasirye P; Munube D; Idro R; Hume H; Pfeffer B; LaRussa P; Green NS
    J Paediatr Child Health; 2019 Jul; 55(7):795-801. PubMed ID: 30411430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Reactions to Pneumococcal Vaccine in Pediatric and Adolescent Patients with Sickle Cell Disease.
    Han J; Kemiki O; Hsu LL; Rivers AE
    Pharmacotherapy; 2015 Jul; 35(7):696-700. PubMed ID: 26095207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Provision of pneumococcal prophylaxis for publicly insured children with sickle cell disease.
    Sox CM; Cooper WO; Koepsell TD; DiGiuseppe DL; Christakis DA
    JAMA; 2003 Aug; 290(8):1057-61. PubMed ID: 12941678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of a 7-valent pneumococcal conjugate vaccine (PCV7) and impact on carriage in Venezuelan children at risk of invasive pneumococcal diseases.
    Rivera-Olivero IA; Del Nogal B; Fuentes M; Cortez R; Bogaert D; Hermans PW; Waard JH
    Vaccine; 2014 Jun; 32(31):4006-11. PubMed ID: 24837505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Streptococcus pneumoniae-related illnesses in young children: secular trends and regional variation.
    Poehling KA; Szilagyi PG; Edwards K; Mitchel E; Barth R; Hughes H; Lafleur B; Schaffer SJ; Schwartz B; Griffin MR
    Pediatr Infect Dis J; 2003 May; 22(5):413-8. PubMed ID: 12792380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine effectiveness of the pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against clinically suspected invasive pneumococcal disease: a cluster-randomised trial.
    Palmu AA; Jokinen J; Nieminen H; Syrjänen R; Ruokokoski E; Puumalainen T; Moreira M; Schuerman L; Borys D; Kilpi TM
    Lancet Respir Med; 2014 Sep; 2(9):717-27. PubMed ID: 25127244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of conjugate pneumococcal vaccination on routine childhood vaccination and primary care use in 2 counties.
    Szilagyi PG; Griffin MR; Shone LP; Barth R; Zhu Y; Schaffer S; Ambrose S; Roy J; Poehling KA; Edwards KM; Walker FJ; Schwartz B;
    Pediatrics; 2006 Oct; 118(4):1394-402. PubMed ID: 17015528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Declining invasive pneumococcal disease in the U.S. elderly.
    McBean AM; Park YT; Caldwell D; Yu X
    Vaccine; 2005 Dec; 23(48-49):5641-5. PubMed ID: 16111788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial.
    Palmu AA; Jokinen J; Borys D; Nieminen H; Ruokokoski E; Siira L; Puumalainen T; Lommel P; Hezareh M; Moreira M; Schuerman L; Kilpi TM
    Lancet; 2013 Jan; 381(9862):214-22. PubMed ID: 23158882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of 7-valent pneumococcal conjugate vaccine in the prevention of invasive pneumococcal disease in children aged 7-59 months. A matched case-control study.
    Domínguez A; Ciruela P; García-García JJ; Moraga F; de Sevilla MF; Selva L; Coll F; Muñoz-Almagro C; Planes AM; Codina G; Jordán I; Esteva C; Hernández S; Soldevila N; Cardeñosa N; Batalla J; Salleras L
    Vaccine; 2011 Nov; 29(48):9020-5. PubMed ID: 21939724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination.
    Adamkiewicz TV; Sarnaik S; Buchanan GR; Iyer RV; Miller ST; Pegelow CH; Rogers ZR; Vichinsky E; Elliott J; Facklam RR; O'Brien KL; Schwartz B; Van Beneden CA; Cannon MJ; Eckman JR; Keyserling H; Sullivan K; Wong WY; Wang WC
    J Pediatr; 2003 Oct; 143(4):438-44. PubMed ID: 14571216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.